샘플 요청 목록

 카트 문의
시장보고서
상품코드
1842324

세계의 생리식염수 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 용기별, 용량별, 최종 용도별, 지역별), 부문별 예측(2025-2033년)

Physiological Saline Market Size, Share & Trends Analysis Report By Product (Intravenous (IV) Saline Solutions, Nasal Irrigation Solutions), By Container, By Volume, By End Use, By Region, And Segment Forecasts, 2025 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생리식염수 시장 요약

세계의 생리식염수 시장 규모는 2024년에 52억 4,000만 달러로 평가되었고, 2033년에는 95억 4,000만 달러에 이르고, 2025년부터 2033년까지 연평균 복합 성장률(CAGR)은 6.97%를 보일 전망입니다.

이 산업의 성장은 수술 건수 증가, 투석이 필요한 신장 질환과 같은 만성 질환의 유행, 수분 보충 및 약물 전달을 위한 정맥주사에 식염수를 광범위하게 사용함에 따라 성장하고 있습니다.

상처 관개, 안과 시술, 비강 관리 등의 용도가 증가함에 따라 수요가 더욱 확대되고 있습니다. 또한, 재택의료로의 전환, 전 세계적인 고령화 추세로 인한 입원 수요 증가, 플렉서블 용기 및 소용량 바이알과 같은 포장 형태에 대한 지속적인 제품 혁신이 시장 성장을 견인하고 있습니다.

입원 환자 수 증가와 정맥주사 의존도 증가는 식염수 산업을 견인하는 주요 요인입니다. 식염수는 입원 환자의 수분 보충, 전해질 균형, 약물 운반체로 가장 일반적으로 사용되는 점적액입니다. 만성질환, 감염성 질환, 응급 입원이 증가함에 따라 병원에서는 유연한 용기나 병에 담긴 대용량 식염수에 대한 수요가 증가하고 있습니다. 중환자실 확대와 급성기 및 장기 치료 모두에서 정맥주사 요법에 대한 선호도가 시장의 꾸준한 성장을 직접적으로 견인하고 있습니다.

무균 0.9% 식염수는 상처 관개, 조직 세척, 체액 교환, 정맥주입 등 거의 모든 수술에서 중요한 요건이기 때문에 수술 건수 증가와 증가는 식염수 산업의 주요 견인차 역할을 하고 있습니다. 만성 질환, 외상, 선택적 수술의 전 세계적인 증가는 일반, 정형외과, 심혈관, 안과 수술에 대한 사용으로 병원과 수술센터의 식염수 수요를 촉진하고 있습니다. 2024 Procedural Statistics Release에 따르면, 2024년에는 약 1,585,878건의 성형수술이 이루어질 것으로 예상되며, 2023년에 비해 1% 증가하였습니다. 마찬가지로 Aesthetic Society의 데이터에 따르면 미용 수술은 2022년부터 2023년까지 2.9% 증가하여 수술 건수의 지속적인 확장을 반영하여 식염수에 대한 수요 증가를 강화할 것으로 보입니다.

만성 상처, 특히 당뇨병성 족부 궤양과 욕창 증가 추세는 생리식염수 시장의 중요한 촉진요인입니다. 이러한 질환에서는 감염을 예방하고 치유를 촉진하기 위해 멸균 식염수를 이용한 잦은 상처 세척과 관류가 필요하기 때문입니다. 2025년 3월, MDPI는 당뇨병으로 인한 가장 심각한 합병증 중 하나로 당뇨병성 족부궤양을 꼽았으며, 전 세계적으로 매년 약 1,860만 명이 앓고 있으며, 당뇨병 관련 하지 절단의 약 80%를 차지한다고 밝혔습니다. 당뇨병 환자의 최대 25%는 당뇨병성 족부 발병 위험이 있으며, 19%-34%는 평생 동안 궤양을 경험하는 것으로 추정됩니다. 이를 뒷받침하듯, 2023년 11월 JAMA의 연구에 따르면 당뇨병 환자 3명 중 1명(33.33%)이 족부궤양을 앓고 있으며, 미국에서는 연간 160만 명이 족부궤양을 앓고 있으며, Trios Health(2023년 10월)는 매년 약 200만 명의 미국인이 당뇨병성 족부궤양을 앓고 있다고 보고했습니다. 당뇨병성 족부궤양을 앓고 있다고 지적하고 있습니다. 이러한 상처는 발생률이 높고 재발이 잦기 때문에 상처 관리에 필수적인 식염수에 대한 수요가 지속적으로 증가하고 있습니다.

재택의료와 외래진료의 확대로 바이알, 프리필드시린지, 플렉서블 용기 등 편리하고 소량 포장 형태에 대한 수요가 증가하면서 식염수 시장을 견인하고 있습니다. 비용 효율적인 환자 중심 의료로의 전환이 진행되면서 정맥주사, 상처 관개, 비강 관리, 안과 시술 등 전통적인 병원 환경 외에서 관리되는 치료가 증가하고 있습니다. 이러한 추세는 특히 노인 인구 증가, 만성질환 관리 수요, 휴대용 수액 시스템의 발전으로 뒷받침되고 있습니다. 그 결과, 가정 및 외래 환자 환경에서 식염수에 대한 접근성과 사용의 용이성이 시장의 꾸준한 성장에 박차를 가하고 있습니다.

FDA가 스페인 사비나니고 시설을 0.9% 염화나트륨 주사제(USP) 제조 시설로 승인한 것은 미국 식염수 시장에 중요한 발전입니다. 이번 이전은 공급의 안전성을 높이고 의료 서비스 제공업체에게 영향을 미치는 식염수의 지속적인 부족에 대응하기 위한 것입니다. 새로운 생산 능력을 추가하고 다양한 용량(250mL, 500mL, 1000mL)공급을 보장함으로써 이번 승인은 식염수 공급망의 탄력성을 강화하고 병원 및 수술센터에서 중단 없는 임상 사용을 지원하며 시장 성장을 가속할 수 있습니다.

목차

제1장 분석 방법, 범위

제2장 주요 요약

제3장 생리식염수 시장 : 변동 요인, 동향 및 범위

  • 시장 연관 전망
    • 부수 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 시장 기회 분석
    • 시장이 해결해야 할 과제 분석
  • 생리식염수 시장 : 분석 툴
    • 업계 분석 : Porter의 Five Forces 분석
    • PESTEL 분석

제4장 생리식염수 시장 : 제품별 추정, 동향 분석

  • 부문 대시보드
  • 생리식염수 시장 : 변동 분석과 시장 점유율, 제품별(2024년, 2033년)
  • 정맥내(IV) 식염수
  • 코 세정 용액
  • 점안용 식염수
  • 상처 세척 및 세정 용액

제5장 생리식염수 시장 : 용기별 추정, 동향 분석

  • 부문 대시보드
  • 생리식염수 시장 : 변동 분석과 시장 점유율, 용기별(2024년, 2033년)
  • 유연 포장 용기
  • 페트병
  • 바이알

제6장 생리식염수 시장 : 용량별 추정, 동향 분석

  • 부문 대시보드
  • 생리식염수 시장 : 변동 분석과 시장 점유율, 용량별(2024년, 2033년)
  • 1000mm
  • 500mm
  • 250mm
  • 250mm 미만
  • 1000mm 이상

제7장 생리식염수 시장 : 최종 용도별 추정, 동향 분석

  • 부문 대시보드
  • 생리식염수 시장 : 변동 분석과 시장 점유율, 최종 용도별(2024년, 2033년)
  • 병원 및 클리닉
  • 외래수술센터(ASC)
  • 재택치료
  • 검사실 및 연구

제8장 생리식염수 시장 : 지역별 추정, 동향 분석(제품별, 용기별, 용량별, 최종 용도별)

  • 지역별 전망
  • 생리식염수 시장 : 변동 분석과 시장 점유율, 지역별(2024년, 2033년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제9장 경쟁 구도

  • 시장 진출기업 분류
  • 주요 기업 개요
    • B. Braun Medical Inc.
    • Baxter
    • Fresenius SE &Co. KGaA
    • Pfizer Inc.
    • ICU Medical, Inc.
    • Medline Industries, LP.
    • AirLife
    • Amsino International, Inc.
    • AdvaCare Pharma
    • Advin Health Care
    • WAMIN(Suppliers, Exporters, and Manufacturers China Medicine)
  • 시장 점유율 분석 : 기업별(2024년)
LSH 25.11.14

Physiological Saline Market Summary

The global physiological saline market size was estimated at USD 5.24 billion in 2024 and is projected to reach USD 9.54 billion by 2033, growing at a CAGR of 6.97% from 2025 to 2033. The growth of the industry is attributed to the rising number of surgical procedures, prevalence of chronic diseases such as kidney disorders requiring dialysis, and the extensive use of saline in IV infusions for hydration and drug delivery.

Increasing applications in wound irrigation, ophthalmic procedures, and nasal care further expand demand. In addition, the shift toward home-based healthcare, an aging global population with higher hospitalization needs, and continuous product innovations in packaging formats such as flexible containers and small-volume vials are fueling market growth.

Rising inpatient admissions and the increasing reliance on IV therapy are major factors driving the physiological saline industry. Saline is the most commonly used IV fluid for hydration, electrolyte balance, and as a carrier for medications in hospitalized patients. With the growing incidence of chronic illnesses, infectious diseases, and emergency admissions, hospitals are witnessing higher demand for large-volume saline solutions in flexible containers and bottles. The expansion of critical care units, coupled with a preference for IV therapy in both acute and long-term treatment settings, directly fuels the steady growth of the market.

High and rising surgical volumes are a major driver of the physiological saline industry, as sterile 0.9% saline is a critical requirement in nearly all procedures for wound irrigation, tissue cleaning, fluid replacement, and IV infusion. The increasing global burden of chronic diseases, trauma cases, and elective surgeries is fueling the demand for saline solutions across hospitals and surgical centers, supported by their use in general, orthopedic, cardiovascular, and ophthalmic surgeries. According to the 2024 Procedural Statistics Release, approximately 1,585,878 cosmetic surgeries were performed in 2024, representing a 1% increase compared to 2023, while reconstructive procedures rose by 2% during the same period, underscoring steady growth in surgical interventions. Similarly, data from the Aesthetic Society highlighted that cosmetic surgical procedures grew 2.9% from 2022 to 2023, reflecting the continuous expansion of surgical volumes and reinforcing the rising demand for physiological saline.

The rising prevalence of chronic wounds, particularly diabetic foot ulcers and pressure ulcers, is a significant driver of the market for physiological saline, as these conditions require frequent wound cleaning and irrigation with sterile saline to prevent infection and promote healing. In March 2025, MDPI noted diabetic foot as one of the most serious complications of diabetes, affecting around 18.6 million people globally each year and accounting for nearly 80% of diabetes-related lower limb amputations. It is estimated that up to 25% of individuals with diabetes are at risk of developing diabetic foot, with 19%-34% likely to experience ulcers during their lifetime. Supporting this, a JAMA study in November 2023 reported that one in three diabetic patients (33.33%) develops foot ulcers, impacting 1.6 million individuals annually in the U.S., while Trios Health (October 2023) noted that around 2 million Americans develop diabetic foot ulcers each year. Such wounds' high incidence and recurrence drive consistent demand for physiological saline solutions as an essential component of wound management.

The expansion of home and outpatient care is driving the market for physiological saline by increasing demand for convenient, smaller-volume packaging formats such as vials, prefilled syringes, and flexible containers. With the growing shift toward cost-effective and patient-centered healthcare, more treatments such as IV infusions, wound irrigation, nasal care, and ophthalmic procedures are being managed outside traditional hospital settings. This trend is particularly supported by the rising elderly population, chronic disease management needs, and advancements in portable infusion systems. As a result, the accessibility and ease of use of saline solutions in home and outpatient environments are fueling steady market growth.

The FDA's approval of Baxter's Sabinanigo, Spain, facility as a manufacturing site for 0.9% Sodium Chloride Injection, USP, is a key development for the U.S. physiological saline market. This move enhances supply security and addresses the ongoing shortages of saline solutions impacting healthcare providers. By adding new production capacity and ensuring availability in multiple volumes (250 mL, 500 mL, and 1000 mL), the approval strengthens the resilience of the saline supply chain and supports uninterrupted clinical use across hospitals and surgical centers, thereby driving market growth.

Global Physiological Saline Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global physiological saline market report on the basis of product, container, volume, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Intravenous (IV) Saline Solutions
  • Nasal Irrigation Solutions
  • Ophthalmic Saline
  • Wound Irrigation and Cleaning Solutions
  • Container Outlook (Revenue, USD Million, 2021 - 2033)
  • Flexible Container
  • Plastic Bottles
  • Vial
  • Volume Outlook (Revenue, USD Million, 2021 - 2033)
  • 1000 ML
  • 500 ML
  • 250 ML
  • Less Than 250
  • More Than 1000 ml
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Home Care Settings
  • Laboratory & Research
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Third Party Perspective
    • 1.3.5. Primary research
    • 1.3.6. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
  • 1.7. Approach 1: Commodity flow approach
    • 1.7.1. Volume price analysis (Model 2)
  • 1.8. Approach 2: Volume price analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Physiological Saline Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High and Growing Surgical Volumes
      • 3.2.1.2. Rising Inpatient Care and IV Therapy Use
      • 3.2.1.3. Increasing Prevalence Of Chronic Diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Low Product Differentiation & Commoditization
      • 3.2.2.2. Supply Chain Vulnerabilities
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Growing Demand in Emerging Economies
      • 3.2.3.2. Expansion of Home and Outpatient Care
      • 3.2.3.3. Product Innovation in Packaging
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Recurring shortages and recalls
  • 3.3. Physiological Saline Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining Power of Suppliers
      • 3.3.1.2. Bargaining Power of Buyers
      • 3.3.1.3. Threat of Substitutes
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape

Chapter 4. Physiological Saline Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Physiological Saline Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Intravenous (IV) Saline Solutions
    • 4.3.1. Intravenous (IV) Saline Solutions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Nasal Irrigation Solutions
    • 4.4.1. Nasal Irrigation Solutions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Ophthalmic Saline
    • 4.5.1. Ophthalmic Saline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Wound Irrigation and Cleaning Solutions
    • 4.6.1. Wound Irrigation and Cleaning Solutions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Physiological Saline Market: Container Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Physiological Saline Market: Container Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Flexible Container
    • 5.3.1. Flexible Container Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Plastic Bottles
    • 5.4.1. Plastic Bottles Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Vial
    • 5.5.1. Vial Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Physiological Saline Market: Volume Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Physiological Saline Market: Volume Movement Analysis & Market Share, 2024 & 2033
  • 6.3. 1000 ML
    • 6.3.1. 1000 ML Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. 500 ML
    • 6.4.1. 500 ML Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. 250 ML
    • 6.5.1. 250 ML Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Less Than 250 ML
    • 6.6.1. Less Than 250 ML Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. More Than 1000 ML
    • 6.7.1. More Than 1000 ML Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Physiological Saline Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Physiological Saline Market: End Use Movement Analysis & Market Share, 2024 & 2033
  • 7.3. Hospitals & Clinics
    • 7.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Home Care Settings
    • 7.5.1. Home Care Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Laboratory & Research
    • 7.6.1. Laboratory & Research Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Physiological Saline Market: Regional Estimates & Trend Analysis by Product, Container, Volume, End Use

  • 8.1. Regional Outlook
  • 8.2. Physiological Saline Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Scenario
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. U.S. Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Scenario
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Canada Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Scenario
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Mexico Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. UK Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Germany Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Scenario
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. France Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Scenario
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Italy Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Scenario
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Spain Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Scenario
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Denmark Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Scenario
      • 8.4.8.4. Reimbursement Scenario
      • 8.4.8.5. Sweden Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Scenario
      • 8.4.9.4. Reimbursement Scenario
      • 8.4.9.5. Norway Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Japan Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. China Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. Reimbursement Scenario
      • 8.5.4.5. India Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. Reimbursement Scenario
      • 8.5.5.5. South Korea Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Reimbursement Scenario
      • 8.5.6.5. Australia Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Reimbursement Scenario
      • 8.5.7.5. Thailand Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Brazil Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Argentina Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. Reimbursement Scenario
      • 8.7.2.5. South Africa Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Reimbursement Scenario
      • 8.7.3.5. Saudi Arabia Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. Reimbursement Scenario
      • 8.7.4.5. UAE Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Reimbursement Scenario
      • 8.7.5.5. Kuwait Physiological Saline Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. B. Braun Medical Inc.
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Baxter
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Fresenius SE & Co. KGaA
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Pfizer Inc.
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. ICU Medical, Inc.
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. Medline Industries, LP.
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. AirLife
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Amsino International, Inc.
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Product Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. AdvaCare Pharma
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Product Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Advin Health Care
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Product Benchmarking
      • 9.2.10.4. Strategic Initiatives
    • 9.2.11. WAMIN (Suppliers, Exporters, and Manufacturers China Medicine)
      • 9.2.11.1. Company Overview
      • 9.2.11.2. Financial Performance
      • 9.2.11.3. Product Benchmarking
      • 9.2.11.4. Strategic Initiatives
  • 9.3. Company Market Share Analysis, 2024
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제